カテゴリ： Allied Market Research, 世界, 医療/バイオ

ニコチン代替治療のグローバル市場（2021〜2031）：ガム、トローチ剤、パッチ、その他

■ 英語タイトル：Nicotine Replacement Therapy Market By Product (Gums, Lozenges, Patches, Others), By Sales Channel (Online, Offline), By Location (Hospitals and Deaddiction centers, Home): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23FB236）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23FB236
■ 発行日：2022年10月
■ 調査対象地域：グローバル
■ 産業分野：ヘルスケア
■ ページ数：290
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ニコチン代替治療のグローバル市場（2021〜2031）：ガム、トローチ剤、パッチ、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に2,659.0百万ドルであった世界のニコチン代替治療市場規模が、2031年までに5,955.95百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）8.3%で成長すると予測しています。本レポートは、ニコチン代替治療の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（ガム、トローチ剤、パッチ、その他）分析、販売チャネル別（オンライン、オフライン）分析、場所別（病院・中毒治療センター、家庭）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、Cipla Ltd、Fertin Pharma Limited、GlaxoSmithKline plc、Johnson & Johnson Inc 、Lucy Goods Inc、Pfizer Inc、PL Developments、Rubicon Research Pvt Ltdなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のニコチン代替治療市場規模：製品別
- ガムにおける市場規模
- トローチ剤における市場規模
- パッチにおける市場規模
- その他における市場規模
・世界のニコチン代替治療市場規模：販売チャネル別
- オンラインチャネルの市場規模
- オフラインチャネルの市場規模
・世界のニコチン代替治療市場規模：場所別
- 病院・中毒治療センターにおける市場規模
- 家庭における市場規模
・世界のニコチン代替治療市場規模：地域別
- 北米のニコチン代替治療市場規模
- ヨーロッパのニコチン代替治療市場規模
- アジア太平洋のニコチン代替治療市場規模
- 中南米・中東・アフリカのニコチン代替治療市場規模
・企業状況
・企業情報

世界のニコチン代替治療市場は、2021年に26億5,900万ドルと評価され、2022年から2031年までの年平均成長率は8.3%を記録し、2031年には59億5,595万ドルに達すると予測されています。

ニコチン代替治療は、タバコ以外の方法でニコチンを摂取することで、タバコ使用障害者を治療する医学的に承認された方法です。ニコチンガムやパッチなどのニコチン代替製品は、喫煙を止めたときに経験する禁断症状を軽減するためにニコチンを体内に供給し、喫煙衝動を抑える口腔活動の代わりとして機能します。

都市部での高い喫煙率に起因するタバコがんの有病率の増加が、ニコチン代替治療市場の成長を牽引しています。また、農村部では男女ともにタバコを噛む率が高く、これがさらに癌のリスクを高めています。例えば、2020年10月に発表された米国癌協会（ACS）の報告書によると、タバコの使用は依然として米国における予防可能な主要死因であり、毎年約5人に1人が死亡しています。同じ出典によると、喫煙は米国における全がんの約20％、がんによる死亡の約30％を引き起こしています。
さらに、がんに対する意識の高まりや、たばこ消費に伴うリスクについての認識を促進するための各国政府によるイニシアチブの増加が、市場の成長に寄与しています。さらに、さまざまな非政府組織や非営利組織が喫煙の有害な影響についての認識を促進するために活動しており、これがニコチン代替治療の需要をさらに押し上げています。

禁煙の動機付けとなるソーシャルメディアの啓発キャンペーンや政府の啓発プログラムにより、ニコチンガムやパッチなどの禁煙補助剤の需要が増加していることも、市場成長に十分な機会を提供しています。ニコチン代替治療は禁断症状を軽減し、タバコを吸いたくなる気持ちを抑えるのに役立ちます。
さらに、先進的なニコチン代替療法の開発のための研究開発活動の増加、製品の承認、主要企業による新規製品の発売が市場の成長を後押ししています。ニコチンガムやトローチのような患者中心の製品開発は、ニコチン代替製品の需要を促進します。しかし、政府の厳しい規制や多くの国での電子タバコの禁止は、市場の成長を妨げる可能性があります。

ニコチン代替治療市場は、製品、販売チャネル、場所、地域によって区分されます。製品別では、ガム、トローチ、パッチ、その他に分類されます。販売チャネル別では、オンラインとオフラインに分けられます。場所別では、病院・検疫所と家庭に分類されます。病院・検疫所はさらに男性と女性に分けられ、家庭部門もさらに男性と女性に二分されます。地域別では、市場は北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

本レポートに掲載されている主要企業には、Cipla Limited、Fertin Pharma Ltd.、GlaxoSmithKline plc、Johnson & Johnson Inc.、Lucy Goods, Inc.、Pfizer Inc.、PL Developments、Rubicon Research Pvt. Ltd.、Sparsha Pharma International Pvt. Ltd.、Zydus Cadilaなどがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までのニコチン代替治療市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢なニコチン代替治療市場機会を特定します。
・主な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・ニコチン代替治療市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界のニコチン代替治療市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品別
ガム
ロゼンジ
パッチ
その他

販売チャネル別
オンライン
オフライン

場所別
病院・脱中毒センター
家庭

地域別
・北米
アメリカ
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Cipla Ltd
Fertin Pharma Limited
GlaxoSmithKline plc
Johnson & Johnson Inc
Lucy Goods Inc
Pfizer Inc
PL Developments
Rubicon Research Pvt Ltd
Sparsha Pharma International Pvt. Ltd.
Zydus Cadila

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities
3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2. Gums
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Lozenges
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Patches
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5. Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
CHAPTER 5: NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL
5.1 Overview
5.1.1 Market size and forecast
5.2. Online
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Offline
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION
6.1 Overview
6.1.1 Market size and forecast
6.2. Hospitals and Deaddiction centers
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.2.4 Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
6.2.4.1 Male Market size and forecast, by region
6.2.4.2 Female Market size and forecast, by region
6.3. Home
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.3.4 Home Nicotine Replacement Therapy Market by Gender
6.3.4.1 Male Market size and forecast, by region
6.3.4.2 Female Market size and forecast, by region
CHAPTER 7: NICOTINE REPLACEMENT THERAPY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Sales Channel
7.2.4 North America Market size and forecast, by Location
7.2.4.1 North America Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
7.2.4.2 North America Home Nicotine Replacement Therapy Market by Gender
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product
7.2.5.1.3 Market size and forecast, by Sales Channel
7.2.5.1.4 Market size and forecast, by Location
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product
7.2.5.2.3 Market size and forecast, by Sales Channel
7.2.5.2.4 Market size and forecast, by Location
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product
7.2.5.3.3 Market size and forecast, by Sales Channel
7.2.5.3.4 Market size and forecast, by Location
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Sales Channel
7.3.4 Europe Market size and forecast, by Location
7.3.4.1 Europe Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
7.3.4.2 Europe Home Nicotine Replacement Therapy Market by Gender
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product
7.3.5.1.3 Market size and forecast, by Sales Channel
7.3.5.1.4 Market size and forecast, by Location
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product
7.3.5.2.3 Market size and forecast, by Sales Channel
7.3.5.2.4 Market size and forecast, by Location
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product
7.3.5.3.3 Market size and forecast, by Sales Channel
7.3.5.3.4 Market size and forecast, by Location
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product
7.3.5.4.3 Market size and forecast, by Sales Channel
7.3.5.4.4 Market size and forecast, by Location
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product
7.3.5.5.3 Market size and forecast, by Sales Channel
7.3.5.5.4 Market size and forecast, by Location
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product
7.3.5.6.3 Market size and forecast, by Sales Channel
7.3.5.6.4 Market size and forecast, by Location
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Sales Channel
7.4.4 Asia-Pacific Market size and forecast, by Location
7.4.4.1 Asia-Pacific Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
7.4.4.2 Asia-Pacific Home Nicotine Replacement Therapy Market by Gender
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product
7.4.5.1.3 Market size and forecast, by Sales Channel
7.4.5.1.4 Market size and forecast, by Location
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product
7.4.5.2.3 Market size and forecast, by Sales Channel
7.4.5.2.4 Market size and forecast, by Location
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product
7.4.5.3.3 Market size and forecast, by Sales Channel
7.4.5.3.4 Market size and forecast, by Location
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product
7.4.5.4.3 Market size and forecast, by Sales Channel
7.4.5.4.4 Market size and forecast, by Location
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product
7.4.5.5.3 Market size and forecast, by Sales Channel
7.4.5.5.4 Market size and forecast, by Location
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product
7.4.5.6.3 Market size and forecast, by Sales Channel
7.4.5.6.4 Market size and forecast, by Location
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Sales Channel
7.5.4 LAMEA Market size and forecast, by Location
7.5.4.1 LAMEA Hospitals and Deaddiction centers Nicotine Replacement Therapy Market by Gender
7.5.4.2 LAMEA Home Nicotine Replacement Therapy Market by Gender
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product
7.5.5.1.3 Market size and forecast, by Sales Channel
7.5.5.1.4 Market size and forecast, by Location
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product
7.5.5.2.3 Market size and forecast, by Sales Channel
7.5.5.2.4 Market size and forecast, by Location
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product
7.5.5.3.3 Market size and forecast, by Sales Channel
7.5.5.3.4 Market size and forecast, by Location
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product
7.5.5.4.3 Market size and forecast, by Sales Channel
7.5.5.4.4 Market size and forecast, by Location
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1 Cipla Ltd
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2 Fertin Pharma Limited
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 GlaxoSmithKline plc
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 Johnson & Johnson Inc
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5 Lucy Goods Inc
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Pfizer Inc
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 PL Developments
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 Rubicon Research Pvt Ltd
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 Sparsha Pharma International Pvt. Ltd.
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 Zydus Cadila
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 2. NICOTINE REPLACEMENT THERAPY MARKET FOR GUMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. NICOTINE REPLACEMENT THERAPY MARKET FOR LOZENGES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 4. NICOTINE REPLACEMENT THERAPY MARKET FOR PATCHES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. NICOTINE REPLACEMENT THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 7. NICOTINE REPLACEMENT THERAPY MARKET FOR ONLINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. NICOTINE REPLACEMENT THERAPY MARKET FOR OFFLINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 9. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. NICOTINE REPLACEMENT THERAPY MARKET FOR HOSPITALS AND DEADDICTION CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. GLOBAL HOSPITALS AND DEADDICTION CENTERS NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 12. NICOTINE REPLACEMENT THERAPY MARKET FOR MALE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. NICOTINE REPLACEMENT THERAPY MARKET FOR FEMALE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NICOTINE REPLACEMENT THERAPY MARKET FOR HOME, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. GLOBAL HOME NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 16. NICOTINE REPLACEMENT THERAPY MARKET FOR MALE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. NICOTINE REPLACEMENT THERAPY MARKET FOR FEMALE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 18. NICOTINE REPLACEMENT THERAPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA HOSPITALS AND DEADDICTION CENTERS NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 23. NORTH AMERICA HOME NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 24. NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 26. U.S. NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 27. U.S. NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 29. CANADA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 30. CANADA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 32. MEXICO NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 33. MEXICO NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 36. EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 37. EUROPE HOSPITALS AND DEADDICTION CENTERS NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 38. EUROPE HOME NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 40. GERMANY NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 41. GERMANY NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 42. GERMANY NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 43. FRANCE NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. FRANCE NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 45. FRANCE NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 46. UK NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 47. UK NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 48. UK NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ITALY NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 50. ITALY NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 51. ITALY NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 52. SPAIN NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 53. SPAIN NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 54. SPAIN NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 55. REST OF EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 56. REST OF EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 57. REST OF EUROPE NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 58. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 60. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 61. ASIA-PACIFIC HOSPITALS AND DEADDICTION CENTERS NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 62. ASIA-PACIFIC HOME NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 63. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 64. JAPAN NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 65. JAPAN NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 66. JAPAN NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 67. CHINA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 68. CHINA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 69. CHINA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 70. AUSTRALIA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 71. AUSTRALIA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 72. AUSTRALIA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 73. INDIA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 74. INDIA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 75. INDIA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 76. SOUTH KOREA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 77. SOUTH KOREA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 78. SOUTH KOREA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 79. REST OF ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 80. REST OF ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 81. REST OF ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 82. LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 83. LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 84. LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 85. LAMEA HOSPITALS AND DEADDICTION CENTERS NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. LAMEA HOME NICOTINE REPLACEMENT THERAPY MARKET, BY GENDER, 2021-2031 (REVENUE, $MILLION)
TABLE 87. LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 88. BRAZIL NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 89. BRAZIL NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 90. BRAZIL NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 91. SAUDI ARABIA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 92. SAUDI ARABIA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 93. SAUDI ARABIA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 94. SOUTH AFRICA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 95. SOUTH AFRICA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 96. SOUTH AFRICA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 97. REST OF LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 98. REST OF LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY SALES CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 99. REST OF LAMEA NICOTINE REPLACEMENT THERAPY MARKET, BY LOCATION, 2021-2031 (REVENUE, $MILLION)
TABLE 100. CIPLA LTD: KEY EXECUTIVES
TABLE 101. CIPLA LTD: COMPANY SNAPSHOT
TABLE 102. CIPLA LTD: OPERATING SEGMENTS
TABLE 103. CIPLA LTD: PRODUCT PORTFOLIO
TABLE 104. CIPLA LTD: NET SALES
TABLE 105. CIPLA LTD: KEY STRATERGIES
TABLE 106. FERTIN PHARMA LIMITED: KEY EXECUTIVES
TABLE 107. FERTIN PHARMA LIMITED: COMPANY SNAPSHOT
TABLE 108. FERTIN PHARMA LIMITED: OPERATING SEGMENTS
TABLE 109. FERTIN PHARMA LIMITED: PRODUCT PORTFOLIO
TABLE 110. FERTIN PHARMA LIMITED: NET SALES
TABLE 111. FERTIN PHARMA LIMITED: KEY STRATERGIES
TABLE 112. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
TABLE 113. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 114. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 115. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 116. GLAXOSMITHKLINE PLC: NET SALES
TABLE 117. GLAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 118. JOHNSON & JOHNSON INC : KEY EXECUTIVES
TABLE 119. JOHNSON & JOHNSON INC : COMPANY SNAPSHOT
TABLE 120. JOHNSON & JOHNSON INC : OPERATING SEGMENTS
TABLE 121. JOHNSON & JOHNSON INC : PRODUCT PORTFOLIO
TABLE 122. JOHNSON & JOHNSON INC : NET SALES
TABLE 123. JOHNSON & JOHNSON INC : KEY STRATERGIES
TABLE 124. LUCY GOODS INC: KEY EXECUTIVES
TABLE 125. LUCY GOODS INC: COMPANY SNAPSHOT
TABLE 126. LUCY GOODS INC: OPERATING SEGMENTS
TABLE 127. LUCY GOODS INC: PRODUCT PORTFOLIO
TABLE 128. LUCY GOODS INC: NET SALES
TABLE 129. LUCY GOODS INC: KEY STRATERGIES
TABLE 130. PFIZER INC: KEY EXECUTIVES
TABLE 131. PFIZER INC: COMPANY SNAPSHOT
TABLE 132. PFIZER INC: OPERATING SEGMENTS
TABLE 133. PFIZER INC: PRODUCT PORTFOLIO
TABLE 134. PFIZER INC: NET SALES
TABLE 135. PFIZER INC: KEY STRATERGIES
TABLE 136. PL DEVELOPMENTS: KEY EXECUTIVES
TABLE 137. PL DEVELOPMENTS: COMPANY SNAPSHOT
TABLE 138. PL DEVELOPMENTS: OPERATING SEGMENTS
TABLE 139. PL DEVELOPMENTS: PRODUCT PORTFOLIO
TABLE 140. PL DEVELOPMENTS: NET SALES
TABLE 141. PL DEVELOPMENTS: KEY STRATERGIES
TABLE 142. RUBICON RESEARCH PVT LTD: KEY EXECUTIVES
TABLE 143. RUBICON RESEARCH PVT LTD: COMPANY SNAPSHOT
TABLE 144. RUBICON RESEARCH PVT LTD: OPERATING SEGMENTS
TABLE 145. RUBICON RESEARCH PVT LTD: PRODUCT PORTFOLIO
TABLE 146. RUBICON RESEARCH PVT LTD: NET SALES
TABLE 147. RUBICON RESEARCH PVT LTD: KEY STRATERGIES
TABLE 148. SPARSHA PHARMA INTERNATIONAL PVT. LTD.: KEY EXECUTIVES
TABLE 149. SPARSHA PHARMA INTERNATIONAL PVT. LTD.: COMPANY SNAPSHOT
TABLE 150. SPARSHA PHARMA INTERNATIONAL PVT. LTD.: OPERATING SEGMENTS
TABLE 151. SPARSHA PHARMA INTERNATIONAL PVT. LTD.: PRODUCT PORTFOLIO
TABLE 152. SPARSHA PHARMA INTERNATIONAL PVT. LTD.: NET SALES
TABLE 153. SPARSHA PHARMA INTERNATIONAL PVT. LTD.: KEY STRATERGIES
TABLE 154. ZYDUS CADILA: KEY EXECUTIVES
TABLE 155. ZYDUS CADILA: COMPANY SNAPSHOT
TABLE 156. ZYDUS CADILA: OPERATING SEGMENTS
TABLE 157. ZYDUS CADILA: PRODUCT PORTFOLIO
TABLE 158. ZYDUS CADILA: NET SALES
TABLE 159. ZYDUS CADILA: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 禁煙＆ニコチン依存症治療製品のグローバル市場（2021〜2031）：ニコチン代替治療製品、薬物治療、電子タバコ
  • 卵巣がん治療薬のグローバル市場（2021〜2031）：化学治療、標的治療、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23FB236 )"ニコチン代替治療のグローバル市場（2021〜2031）：ガム、トローチ剤、パッチ、その他" (英文：Nicotine Replacement Therapy Market By Product (Gums, Lozenges, Patches, Others), By Sales Channel (Online, Offline), By Location (Hospitals and Deaddiction centers, Home): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。